+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

From
Anxiety Disorder Treatment: Global Strategic Business Report - Product Thumbnail Image

Anxiety Disorder Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 196 Pages
  • Global
From
Treatment Resistant Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Major Depressive Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Postpartum Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Postpartum Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Schizoaffective Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Serotonin receptor 2 angonist - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin receptor 2 angonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
REXULTI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REXULTI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
General Anxiety Disorder (GAD) - Pipeline Insight, 2024 - Product Thumbnail Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Global Psychedelic Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Psychedelic Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Global Bipolar Disorder Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Bipolar Disorder Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 161 Pages
  • Global
From
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more